furtrethonium
This page covers all furtrethonium drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3.
Targets
Phase 2 pipeline (1)
- Furmethide · Neuroscience
Furmethide works by blocking the action of acetylcholine at the muscarinic acetylcholine receptor M2.
Patent intelligence
- furtrethonium patent landscape — aggregated cliff calendar, attackable patents, originator estates